儘管淨虧損 2.65 億美元，沃爾格林博姿聯盟 (WBA) 股價仍飆漲 23%

沃爾格林博姿聯盟公司（納斯達克股票代碼：WBA）儘管報告最近一個季度淨虧損 2.65 億美元（每股 31 美分），但仍激發了投資者的樂觀情緒。

Walgreens Boots Alliance Inc. (Nasdaq: WBA) stock soared 23.43% to $11.38 per share on January 10 after the company reported a net loss of $265 million (31 cents per share) for the most recent quarter, beating analyst expectations despite the loss.

沃爾格林博姿聯盟公司（納斯達克股票代碼：WBA）1月10日股價飆升23.43%，至每股11.38美元，此前該公司報告最近一個季度淨虧損2.65億美元（每股31美分），儘管虧損，但仍超出了分析師的預期。

The company, which is grappling with the challenges of fiscal 2024, appears to be on the road to recovery, focusing on restructuring and trimming its footprint to regain profitability.

該公司正在努力應對 2024 財年的挑戰，似乎正在走上復甦之路，重點關注重組和削減業務規模，以恢復獲利能力。

Shares of Walgreens soared following the earnings report, signaling that investors are optimistic about the company’s strategic moves for fiscal 2025 and beyond.

沃爾格林的股價在財報發布後飆升，顯示投資者對該公司 2025 財年及以後的策略性舉措持樂觀態度。

One of the key pillars of Walgreens’ recovery plan is its aggressive store closure strategy. The company announced it is closing 1,200 underperforming stores, with 500 slated to be closed in fiscal 2025.

沃爾格林復甦計畫的關鍵支柱之一是其積極的門市關閉策略。該公司宣布將關閉 1,200 家業績不佳的門市，其中 500 家計劃在 2025 財年關閉。

These moves are part of a broader initiative to optimize its retail pharmacy operations, reduce costs, and improve cash flow. The company emphasized that its restructuring efforts, though costly, are essential for stabilizing its business and positioning it for long-term success.

這些措施是優化零售藥房營運、降低成本和改善現金流的更廣泛計劃的一部分。該公司強調，重組工作雖然成本高昂，但對於穩定其業務並為其長期成功至關重要。

“We are taking bold actions to stabilize our Retail Pharmacy by improving operating costs, enhancing cash flow, and addressing reimbursement models, which have impacted our financial results,” said Tim Wentworth, CEO of Walgreens Boots Alliance, in a press release.

沃爾格林博姿聯盟執行長溫特沃斯在一份新聞稿中表示：「我們正在採取大膽行動，透過降低營運成本、增強現金流和解決影響我們財務表現的報銷模式來穩定我們的零售藥局。

“We believe in a sustainable, retail pharmacy-led operating model, and these actions will support our company’s long-term success and value creation for our stakeholders.”

“我們相信以零售藥局為主導的可持續運營模式，這些行動將支持我們公司的長期成功並為利益相關者創造價值。”

While Walgreens is facing challenges, the company has seen growth in several key business areas.

儘管沃爾格林面臨挑戰，但該公司在幾個關鍵業務領域取得了成長。

The retail pharmacy division saw $30.87 billion in quarterly sales, up 6.6% year-over-year. Similarly, Walgreens’ health care division reported $2.17 billion in revenue, marking a 12% increase from the previous year.

零售藥品部門季度銷售額為308.7億美元，較去年同期成長6.6%。同樣，沃爾格林醫療保健部門的收入為 21.7 億美元，比上年增長 12%。

The company’s international unit also saw a healthy uptick in sales, reaching $6.43 billion, a 10.2% increase year-over-year.

該公司的國際部門銷售額也出現健康成長，達到 64.3 億美元，年增 10.2%。

These positive results in multiple sectors provide hope that the company’s focus on healthcare, coupled with its ongoing restructuring efforts, could allow it to weather the storm of its recent losses.

多個行業的這些積極成果為該公司對醫療保健的關注以及持續的重組努力帶來了希望，可以使其渡過近期虧損的風暴。

Amid these developments, there has also been speculation that Walgreens may be in talks to sell itself to private equity firm Sycamore Partners.

在這些事態發展中，也有人猜測沃爾格林可能正在就將自己出售給私募股權公司 Sycamore Partners 進行談判。

While nothing concrete has emerged, the discussions have fueled further interest in Walgreens’ stock.

雖然沒有出現任何具體消息，但討論進一步激發了人們對沃爾格林股票的興趣。

The company’s restructuring, coupled with its healthy growth in multiple sectors, has likely made it an attractive acquisition target for investors looking to capitalize on its turnaround potential.

該公司的重組，加上其在多個領域的健康成長，可能使其成為尋求利用其扭虧為盈潛力的投資者的有吸引力的收購目標。

Despite a significant loss this quarter, Walgreens is setting itself up for a more stable future.

儘管本季出現重大虧損，沃爾格林正在為更穩定的未來做好準備。

The stock surge following its earnings beat suggests investor confidence is high in the company’s ability to recover.

獲利超出預期後股價飆升，顯示投資者對該公司的復甦能力充滿信心。

With its ongoing restructuring efforts, growth in health care and retail pharmacy, and possible acquisition talks, Walgreens is actively working toward regaining its footing in a challenging market environment.

透過持續的重組努力、醫療保健和零售藥房的成長以及可能的收購談判，沃爾格林正在積極努力在充滿挑戰的市場環境中重新站穩腳跟。

The company’s continued efforts to stabilize its operations while pursuing growth in its key business segments could pave the way for a promising year ahead.

該公司繼續努力穩定運營，同時追求關鍵業務領域的成長，這可能為未來充滿希望的一年鋪平道路。